Objective To assess the characteristics of the 6-min walk (6MW) in multiple sclerosis (MS) subjects of varied disability, and controls. To assess the correlation of 6MW to subjective measures of fatigue, health status and ambulation using the modified fatigue impact scale (MFIS), short form-36 Health Questionnaire physical component score and MS walking scale (MSWS).
Methods Forty MS expanded disability status scale [(EDSS) 0—6.5] and 20 control subjects were recruited from a MS outpatient clinic. Subjects completed survey material and three 6MWs with 1-h interval rest in a single study visit.
Results There was no practice effect or fatigability with repeat 6MW tests with a one-h rest period between test sessions. The 6MW had excellent intra-[intraclass correlation coefficient (ICC) = 0.95] and inter-rater (ICC = 0.91) reliability. MS subjects demonstrated reduced 6MW distance and speed compared with controls (P < 0.0001). Within the MS population 6MW distance was significantly reduced with increasing disability (P = 0.05). Compared with the EDSS, the 6MW had a stronger correlation to subjective measures of ambulation and physical fatigue: MSWS (r = -0.81 versus 0.69) and MFISphy (0.66 versus 0.63).
Conclusions The 6MW is a feasible, reproducible, and reliable measure in MS. MS subjects demonstrate motor fatigue in both 6MW distance and speed compared with controls. In MS subjects there is an inverse relationship between motor fatigue and disability. 6MW has a strong correlation to subjective measures of ambulation and physical fatigue. Multiple Sclerosis 2008; 14: 383—390. http://msj.sagepub.com
Fisk JD PA , Ritvo PG, Archibald CJ, Murray TJThe impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci1994; 21: 9-14.
3.
Krupp L., LaRocca N., Muir-Nash J., Steinberg A.The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol1989; 46: 1121-3.
4.
Schwid SR, Thornton CA, Pandya S., Manzur KL, Sanjak M., Pelrie MD et al Quantitative assessment of motor fatigue and strength in MS. Neurology1999; 53(4): 1294-6.
5.
Butland RJA , Pang JA, Gross ER, Woodcock AA, Gedes DMTwo-, six-, and twelve-Minute walking test in respiratory disease. BMJ1982; 284: 1007-8.
6.
Ada L., Dean C., Hall J., Bampton J., Crompton S.A treadmill and overground walking program improves walking in persons residing in the community after stroke: a placebo-controlled, randomized trial . Arch Phys Med Rehabil2003; 84: 1486-91.
7.
Dean C., Richards C., Malouni F.Task related circut training improves locomotor tasks in chronic stroke . Arch Phys Med Rehabil2000; 81: 409-17.
8.
Daly JJ, Roenigk K., Holcomb J., Rogess JM, Butler K., Gansen J., et al. A randomized controlled trial of functional neuromuscular stimulation in chronic stroke subjects. Stroke2006; 37: 172-78.
9.
Duncan P., Studenski S., Richards L., Gollub S., Lai SM, Rekes D., et al. Randomized clinical trial of therapeutic excercise in subacute stroke. Stroke2000; 34: 2173-80.
10.
Garber C., Friedman J.Effects of fatigue on physical activity and function in patients with Parkinson's Disease. Neurology2003; 60: 1119-24.
11.
Chetta A., Rampello A., Marangio E., Merlini S., Dazzi F., Aiello M. et al. Cardiorespi-ratory response to walk in multiple sclerosis patients . Respir Med2004; 98: 522-9.
12.
Savci S., Inal-Ince S., Arikan H., Guelu-Gunduz A., Cetisli-Korkmaz N., Armutlu K., et al. Six minute walk distance as a measure of functional exercise capacity in multiple sclerosis. Disabil Rehabil2005; 27: 1365-71.
13.
Lublin FD, Reingold SCDefining the clinical course of multiple sclerosis: results of an international survey. Neurology1996; 46: 907-11.
14.
Society ATATS Statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med2002; 166: 111-7.
15.
Kurtzke JFRating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology1983; 33: 1444-52.
16.
Rudick R., Antel J., Confavreux C., Cutter G., Ellison G., Frisihes J., et al. Recommenda-tions from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol1997; 42: 379-82.
17.
Fisk J., Ritvo P., Ross L., Hasse D., Marrie T., Schlech W.Measuring the functional impact of fatigue: initial validation of the FIH . Clin Inf Dis1994; 18(suppl 1): S79-83.
18.
Steward A.Functional status and well-being of patients with chronic conditions: results from the medical outcomes study. JAMA1989 ; 262: 907-13.
19.
Hobart J., Riazi A., Lamping DL, Fitzpatrick R., Thompson AJMeasuring the impact of MS on walking ability. Neurology2003; 60(1): 31-6.
20.
McGuigan C. , Hutchinson M.Confirming the validity and responsiveness of the multiple sclerosis walking scale-12 (MSWS-12). Neurology2004; 62(11): 2103-5.
21.
McHorney C. , Ware J., Raczek A.The MOS 36-item Short Form Health Survey (SF-36): II psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care1993; 31: 247-63.
22.
Wu G., Sanderson B., Bittner V.The 6-minute walk test: how important is learning effect. Am Heart J2003; 146: 129-33.
23.
Pankoff PA, Overend TJ, Lucy SD, White KPReliability of the Six-Minute Walk test in people with Fibromyalgia . Arthritis Care and Research2000; 13(5): 291-5.
24.
Flachenecker P., Kumpfel T., Kallamann B., et al. Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Multiple Sclerosis2002; 8: 523-6.
25.
Gottberg K. , Gardulf A., Fredrikson S.Interferon-beta treatment for patients with multiple sclerosis: the patients' perceptions of the side-effects . Multiple Sclerosis2000; 6: 349-54.
26.
Schwid S., Petrie M., McDermott M., Tierney D., Mason D., Goodman A.Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis. Neurology1997; 28: 817-21.
27.
Enright PL SD. Reference equations for the six-minute walk in healthy individuals . Am J Respir Crit Care Med1998; 158: 1384-7.
28.
Troosters T. , Gosselink R., Decramer M.Six minute walking distance in healthy elderly subjects. European Respir J1999; 14: 270-4.
